Literature DB >> 29596578

OPTIMIST trial: optimistic evidence?

Sesh Kamal Sunkara1, Nikolaos P Polyzos2.   

Abstract

Entities:  

Year:  2018        PMID： 29596578     DOI： 10.1093/humrep/dey062

Source DB:  PubMed          Journal:  Hum Reprod        ISSN： 0268-1161            Impact factor:   6.918


× No keyword cloud information.
  5 in total

Review 1.  Dose adjustment of follicle-stimulating hormone (FSH) during ovarian stimulation as part of medically-assisted reproduction in clinical studies: a systematic review covering 10 years (2007-2017).

Authors:  Human Fatemi; Wilma Bilger; Deborah Denis; Georg Griesinger; Antonio La Marca; Salvatore Longobardi; Mary Mahony; Xiaoyan Yin; Thomas D'Hooghe
Journal:  Reprod Biol Endocrinol       Date:  2021-05-11       Impact factor: 5.211

Review 2.  Management Strategies for POSEIDON Groups 3 and 4.

Authors:  Thor Haahr; Carlos Dosouto; Carlo Alviggi; Sandro C Esteves; Peter Humaidan
Journal:  Front Endocrinol (Lausanne)       Date:  2019-09-11       Impact factor: 5.555

3.  Individualized ovarian stimulation in IVF/ICSI treatment: it is time to stop using high FSH doses in predicted low responders.

Authors:  Jori A Leijdekkers; Helen L Torrance; Nienke E Schouten; Theodora C van Tilborg; Simone C Oudshoorn; Ben Willem J Mol; Marinus J C Eijkemans; Frank J M Broekmans
Journal:  Hum Reprod       Date:  2020-09-01       Impact factor: 6.918

Review 4.  The POSEIDON stratification - moving from poor ovarian response to low prognosis.

Authors:  Matheus Roque; Thor Haahr; Sandro C Esteves; Peter Humaidan
Journal:  JBRA Assist Reprod       Date:  2021-04-27

5.  Recombinant Human Follicle-Stimulating Hormone Alfa Dose Adjustment in US Clinical Practice: An Observational, Retrospective Analysis of a Real-World Electronic Medical Records Database.

Authors:  Mary C Mahony; Brooke Hayward; Gilbert L Mottla; Kevin S Richter; Stephanie Beall; G David Ball; Thomas D'Hooghe
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-09       Impact factor: 5.555
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.